Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19929272 | 1.00 | TSHR (0.39) | TSHRCYP3A4ALDH1A1THRBMEN1 | |
| SCHEMBL11995956 | 0.94 | TSHR (0.39) | TSHRCYP3A4ALDH1A1THRBMEN1 | |
| SCHEMBL31021559 | 0.94 | THRB (0.41) | TSHRCYP3A4ALDH1A1THRBMEN1 | |
| SCHEMBL5344 | 0.94 | — | — | |
| SCHEMBL28983025 | 0.94 | ALDH1A1 (0.43) | TSHRCYP3A4ALDH1A1THRBHTT | |
| SCHEMBL5956557 | 0.88 | — | — | |
| SCHEMBL987113 | 0.88 | TSHR (0.40) | TSHRCYP3A4ALDH1A1THRBMEN1 | |
| SCHEMBL4424020 | 0.88 | TSHR (0.40) | TSHRCYP3A4ALDH1A1THRBMEN1 | |
| SCHEMBL10057430 | 0.88 | ALDH1A1 (0.47) | TSHRCYP3A4ALDH1A1THRBMEN1 | |
| SCHEMBL9672437 | 0.88 | ALDH1A1 (0.47) | TSHRCYP3A4ALDH1A1THRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590198-B2 | Process for the decomposition of polyurethane | NEVEON GERMANY GMBH (DE) | 2026-03-31 | — | — | US | disclosed |
| US-20240301161-A1 | PROCESS FOR THE DECOMPOSITION OF POLYURETHANE | NEVEON GERMANY GMBH (DE) | 2024-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590198-B2 | Process for the decomposition of polyurethane | TRAM1, PARG, PUF60 | TSHR 4387/4885CYP3A4 1043/4885ALDH1A1 538/4885 |
| US-20240301161-A1 | PROCESS FOR THE DECOMPOSITION OF POLYURETHANE | PUF60, UMPS, UPP1 | TSHR 4808/4885CYP3A4 1282/4885ALDH1A1 1102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.